tiprankstipranks
Trending News
More News >
Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO
Advertisement

Aptevo Therapeutics (APVO) Price & Analysis

Compare
707 Followers

APVO Stock Chart & Stats

$1.57
-$0.30(-5.81%)
At close: 4:00 PM EST
$1.57
-$0.30(-5.81%)

Aptevo Therapeutics News

APVO FAQ

What was Aptevo Therapeutics Inc’s price range in the past 12 months?
Aptevo Therapeutics Inc lowest stock price was $1.32 and its highest was $381.75 in the past 12 months.
    What is Aptevo Therapeutics Inc’s market cap?
    Aptevo Therapeutics Inc’s market cap is $22.37M.
      When is Aptevo Therapeutics Inc’s upcoming earnings report date?
      Aptevo Therapeutics Inc’s upcoming earnings report date is Nov 06, 2025 which is in 15 days.
        How were Aptevo Therapeutics Inc’s earnings last quarter?
        Aptevo Therapeutics Inc released its earnings results on Aug 11, 2025. The company reported -$8.4 earnings per share for the quarter, beating the consensus estimate of -$83.2 by $74.8.
          Is Aptevo Therapeutics Inc overvalued?
          According to Wall Street analysts Aptevo Therapeutics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Aptevo Therapeutics Inc pay dividends?
            Aptevo Therapeutics Inc does not currently pay dividends.
            What is Aptevo Therapeutics Inc’s EPS estimate?
            Aptevo Therapeutics Inc’s EPS estimate is -2.09.
              How many shares outstanding does Aptevo Therapeutics Inc have?
              Aptevo Therapeutics Inc has 13,808,966 shares outstanding.
                What happened to Aptevo Therapeutics Inc’s price movement after its last earnings report?
                Aptevo Therapeutics Inc reported an EPS of -$8.4 in its last earnings report, beating expectations of -$83.2. Following the earnings report the stock price went down -4.867%.
                  Which hedge fund is a major shareholder of Aptevo Therapeutics Inc?
                  Currently, no hedge funds are holding shares in APVO

                  Company Description

                  Aptevo Therapeutics Inc

                  Aptevo Therapeutics (APVO) is a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics aimed at providing innovative treatments for cancer and other life-threatening diseases. The company operates primarily in the biotechnology and pharmaceutical sectors, leveraging its proprietary ADAPTIR and ADAPTIR-FLEX platforms to create bispecific antibody therapeutics. Aptevo's core products include APVO436, a bispecific antibody candidate targeting acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), among other developmental candidates.

                  Aptevo Therapeutics (APVO) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  VivoSim Labs
                  Enveric Biosciences
                  Ensysce Biosciences
                  Revelation Biosciences
                  Tao Synergies

                  Ownership Overview

                  <0.01%<0.01%0.03%100.00%
                  <0.01% Insiders
                  0.03% Other Institutional Investors
                  100.00% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis